324 related articles for article (PubMed ID: 30482247)
1. Merkel cell polyomavirus-specific immune responses in patients with Merkel cell carcinoma receiving anti-PD-1 therapy.
Miller NJ; Church CD; Fling SP; Kulikauskas R; Ramchurren N; Shinohara MM; Kluger HM; Bhatia S; Lundgren L; Cheever MA; Topalian SL; Nghiem P
J Immunother Cancer; 2018 Nov; 6(1):131. PubMed ID: 30482247
[TBL] [Abstract][Full Text] [Related]
2. Merkel Cell Carcinoma in the Age of Immunotherapy: Facts and Hopes.
Colunga A; Pulliam T; Nghiem P
Clin Cancer Res; 2018 May; 24(9):2035-2043. PubMed ID: 29217527
[TBL] [Abstract][Full Text] [Related]
3. Robust Production of Merkel Cell Polyomavirus Oncogene Specific T Cells From Healthy Donors for Adoptive Transfer.
Davies SI; Barrett J; Wong S; Chang MJ; Muranski PJ; Brownell I
Front Immunol; 2020; 11():592721. PubMed ID: 33362774
[TBL] [Abstract][Full Text] [Related]
4. Merkel cell polyomavirus-specific CD8⁺ and CD4⁺ T-cell responses identified in Merkel cell carcinomas and blood.
Iyer JG; Afanasiev OK; McClurkan C; Paulson K; Nagase K; Jing L; Marshak JO; Dong L; Carter J; Lai I; Farrar E; Byrd D; Galloway D; Yee C; Koelle DM; Nghiem P
Clin Cancer Res; 2011 Nov; 17(21):6671-80. PubMed ID: 21908576
[TBL] [Abstract][Full Text] [Related]
5. Tumor-Infiltrating Merkel Cell Polyomavirus-Specific T Cells Are Diverse and Associated with Improved Patient Survival.
Miller NJ; Church CD; Dong L; Crispin D; Fitzgibbon MP; Lachance K; Jing L; Shinohara M; Gavvovidis I; Willimsky G; McIntosh M; Blankenstein T; Koelle DM; Nghiem P
Cancer Immunol Res; 2017 Feb; 5(2):137-147. PubMed ID: 28093446
[TBL] [Abstract][Full Text] [Related]
6. Quality Is King: Fundamental Insights into Tumor Antigenicity from Virus-Associated Merkel Cell Carcinoma.
Lahman MC; Paulson KG; Nghiem PT; Chapuis AG
J Invest Dermatol; 2021 Aug; 141(8):1897-1905. PubMed ID: 33863500
[TBL] [Abstract][Full Text] [Related]
7. Virus-positive Merkel Cell Carcinoma Is an Independent Prognostic Group with Distinct Predictive Biomarkers.
Harms KL; Zhao L; Johnson B; Wang X; Carskadon S; Palanisamy N; Rhodes DR; Mannan R; Vo JN; Choi JE; Chan MP; Fullen DR; Patel RM; Siddiqui J; Ma VT; Hrycaj S; McLean SA; Hughes TM; Bichakjian CK; Tomlins SA; Harms PW
Clin Cancer Res; 2021 May; 27(9):2494-2504. PubMed ID: 33547200
[TBL] [Abstract][Full Text] [Related]
8. Insights into anti-tumor immunity
Jani S; Church CD; Nghiem P
Front Immunol; 2023; 14():1172913. PubMed ID: 37287968
[TBL] [Abstract][Full Text] [Related]
9. Expression of the IDO1/TDO2-AhR pathway in tumor cells or the tumor microenvironment is associated with Merkel cell polyomavirus status and prognosis in Merkel cell carcinoma.
Wardhani LO; Matsushita M; Iwasaki T; Kuwamoto S; Nonaka D; Nagata K; Kato M; Kitamura Y; Hayashi K
Hum Pathol; 2019 Feb; 84():52-61. PubMed ID: 30240768
[TBL] [Abstract][Full Text] [Related]
10. Rationale for immune-based therapies in Merkel polyomavirus-positive and -negative Merkel cell carcinomas.
Vandeven N; Nghiem P
Immunotherapy; 2016 Jul; 8(8):907-21. PubMed ID: 27381685
[TBL] [Abstract][Full Text] [Related]
11. Merkel Cell Polyomavirus Infection Induces an Antiviral Innate Immune Response in Human Dermal Fibroblasts.
Krump NA; Wang R; Liu W; Yang JF; Ma T; You J
J Virol; 2021 Jun; 95(13):e0221120. PubMed ID: 33883226
[TBL] [Abstract][Full Text] [Related]
12. Merkel polyomavirus-specific T cells fluctuate with merkel cell carcinoma burden and express therapeutically targetable PD-1 and Tim-3 exhaustion markers.
Afanasiev OK; Yelistratova L; Miller N; Nagase K; Paulson K; Iyer JG; Ibrani D; Koelle DM; Nghiem P
Clin Cancer Res; 2013 Oct; 19(19):5351-60. PubMed ID: 23922299
[TBL] [Abstract][Full Text] [Related]
13. Improved detection suggests all Merkel cell carcinomas harbor Merkel polyomavirus.
Rodig SJ; Cheng J; Wardzala J; DoRosario A; Scanlon JJ; Laga AC; Martinez-Fernandez A; Barletta JA; Bellizzi AM; Sadasivam S; Holloway DT; Cooper DJ; Kupper TS; Wang LC; DeCaprio JA
J Clin Invest; 2012 Dec; 122(12):4645-53. PubMed ID: 23114601
[TBL] [Abstract][Full Text] [Related]
14. Scientific and clinical developments in Merkel cell carcinoma: A polyomavirus-driven, often-lethal skin cancer.
Akaike T; Nghiem P
J Dermatol Sci; 2022 Jan; 105(1):2-10. PubMed ID: 34836718
[TBL] [Abstract][Full Text] [Related]
15. A monoclonal antibody against SV40 large T antigen (PAb416) does not label Merkel cell carcinoma.
Pelletier DJ; Czeczok TW; Bellizzi AM
Histopathology; 2018 Jul; 73(1):162-166. PubMed ID: 29430700
[TBL] [Abstract][Full Text] [Related]
16. Polyomavirus-driven Merkel cell carcinoma: Prospects for therapeutic vaccine development.
Tabachnick-Cherny S; Pulliam T; Church C; Koelle DM; Nghiem P
Mol Carcinog; 2020 Jul; 59(7):807-821. PubMed ID: 32219902
[TBL] [Abstract][Full Text] [Related]
17. Advances in Immunotherapy for Metastatic Merkel Cell Carcinoma: A Clinician's Guide.
Paulson KG; Bhatia S
J Natl Compr Canc Netw; 2018 Jun; 16(6):782-790. PubMed ID: 29891528
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional and functional analyses of neoantigen-specific CD4 T cells during a profound response to anti-PD-L1 in metastatic Merkel cell carcinoma.
Church C; Pulliam T; Longino N; Park SY; Smythe KS; Makarov V; Riaz N; Jing L; Amezquita R; Campbell JS; Gottardo R; Pierce RH; Choi J; Chan TA; Koelle DM; Nghiem P
J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36252564
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the Impact of Merkel Cell Polyomavirus-Induced Interferon Signaling on Viral Infection.
Wang R; Yang JF; Senay TE; Liu W; You J
J Virol; 2023 Apr; 97(4):e0190722. PubMed ID: 36946735
[TBL] [Abstract][Full Text] [Related]
20. Human Merkel cell polyomavirus: virological background and clinical implications.
Coursaget P; Samimi M; Nicol JT; Gardair C; Touzé A
APMIS; 2013 Aug; 121(8):755-69. PubMed ID: 23781869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
